Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-08-30
2005-08-30
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S093440, C424S175100, C424S184100, C424S185100, C424S190100, C424S192100, C424S203100, C424S278100, C424S282100, C435S007340, C435S036000, C435S069100, C435S071100, C530S388400, C530S403000, C536S023700
Reexamination Certificate
active
06936259
ABSTRACT:
The CAMP factor gene ofStreptococcus uberis(S. uberis) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs, including CAMP factor epitopes from more than one bacterial species. The CAMP factors and chimeras including the same can be used in immunogenic compositions for the prevention and treatment of bacterial infections.
REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: 0 626 452 (1994-11-01), None
patent: WO 96/41879 (1996-12-01), None
Frey et al. 1989. Infection and Immunity. 57(7): 2050-2056.
Podbielski et al. 1994. Med. Microbio. Immuno. 183:239-256.
Bernheimer et al., “Nature and Mechanism of Action of the CAMP Protein of Group b Streptococci,”Infection and Immunity23(3):838-844 (1979).
Burgess et al.,J. Cell Biol.111:2129-2138 (1990).
Christie et al., “A Note on a Lytic Phenomenom Shown by Group B Streptococci,”Aus. J. Exp. Bio. Med. Sci.22:197-200 (1944).
Fehrenbach et al., “Interaction of Amphiphilic Bacterial Polypeptides With Artificial Membranes,”Bacterial Protein Tokins,pp. 317-324 (1984).
Fehrenbach et al., “Role of CAMP-Factor (Protein B) for Virulence,” (Eds.)Bacterial Protein Toxins, Zbl. Bakt. Suppl.17:351-357 (1988).
Figura et al., “Differentiation of Motile and Mesophilic Aeromonas Strains Into Species by Testing for a CAMP-Like Factor,”J. Clin. Microbiol.25(7):1341-1342 (1987).
Fraser, Gordon, “Bacteriology: Haemolytic Activity of Corynebacterium,”Nature189:246 (1961).
Frey et al., “Cloning and Expression of a Cohemolysin, the CAMP Factor ofActinobacillus Pleuropneumoniae,” Infection&Immunity57(7):2050-2056 (1989).
Jiang et al., Cloning, Sequencing and Expression of the CAMP Factor Gene ofStreptococcus uberis,20:297-307 (1996).
George et al., “Macromol Sequencing Synthesis,” Select Meth. Appl. Alan Liss Inc. (1988).
Herzog et al.,DNA and Cell Biology12(6):465-471 (1993).
Jürgens et al., “Purification and Characterization of Camp-Factor FromStreptococcus agalactiaeby Hydrophobic Interaction Chromatography and Chromatofocusing,”Journal of Chromatography,348:363-370 (1985).
Jürgens et al., “Unspecific Binding of Group B Streptococcal Cocytolysin (CAMP Factor) to Immunoglobulins and its Possible Roe in Pathogenicity,”J. Exp. Med.165:720-732 (1987).
Kohler, W., “CAMP-Like Phenomena of Vibrios,”Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A270:35-40 (1988).
Lazar et al.,Mol. Cell. Biol.8(3):1247-1252 (1988).
Levinson et al., Examination & Board Review, Medical Microbiology & Immunology pp. 292-293 (1994).
Podbielski,Med. Microbiol. Immunol.183:239-256 (1994).
Rocourt et al., “Notes;Listeria WelshimeriSp. Nov. andListeria SeeligeriSp. Nov.,”International. J. Syst. Bacteriol,33(4):866-869 (1983).
Rudinger et al., “Peptide Hormones,” ed. Parsons, University Park Press (1976).
Rühlmann et al., “Complete Amino Acid Sequence of Protein B,”Fed. of Europ. Biochem. Soc.235 (1,2):262-266 (1988).
Sambrook et al., “Expression of cloned genes inE. coli. ” Molecular Cloning, A Laboratory Manual,Chapter 17, CSH (1989).
Schneewind et al., “Cloning and Expression of the CAMP Factor of Group B Streptococci inEscherichia coli,” Infection&Immunity56(8):2174-2179 (1988).
Skalka et al., “Lethal Effect of CAMP-Factor andUBERIS-Factor-a New Finding About Diffusible Exosubstances ofStreptococcus agalactiaeandStreptococcus uberis,” Zentralbl. Bakteriol. Ser. A249:190-194 (1981).
Sterzik et al., “Interaction of the Camp-Factor FromS. agalactiaeWith Artificial Membranes,”Bacterial Protein Toxins,pp. 195-196 (1984).
Sterzik et al., “Structure and Function of CAMP Factor ofStreptococcus agalactiae, ” Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 115:101-108 (1985).
Williams,Lett. Appl. Microbiol.12(1):23-28 (1991).
Finch et al., “Further studies on the efficacy of a five vaccine against metitis caused byStreptococcus uberis,” Vaccine 15(10):1138-1143, 1997.
Fontaine et al., “Immunization of dairy cattle with recombinantStreptococcus uberisGapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge,” Vaccine 20:2278-2286, 2002.
Fontaine et al., “Immunization of dairy cattle with recombinantStrptococcus uberisGapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge,” Vaccine 20:3047-3048, 2002.
Leigh et al., “Vaccination with the plasminogen activator fromStreptococcus uberisinduces an inhibitory response and protects against experimental infection in the dairy cow,” Vaccine 17:851-857, 1997.
Fontaine Michael
Perez-Casal Jose
Potter Andrew A.
Song Xinming
Hines J.
Robins & Pasternak LLP
Smith Lynette R. F.
University of Saskatchewan
LandOfFree
CAMP factor of Streptococcus uberis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CAMP factor of Streptococcus uberis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CAMP factor of Streptococcus uberis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3489684